PLCB1 Gene

Migration, Crosslink

📖

PLCB1 Gene

active

wiki page Created: 2026-04-02T07:19:19 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-plcb1

📖 Wiki Page

gene1257 wordssynced 2026-04-02

PLCB1 Gene

Overview

...

PLCB1 Gene

Overview

Mermaid diagram (expand to render)

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">PLCB1 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>PLCB1</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Phospholipase C Beta 1</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>20p12.3</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>23236</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>607120</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000141642</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>Q9NQ66</td>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Phospholipase C beta 1 (PLC-beta1)</td>
</tr>
<tr>
<td class="label">Isoform</td>
<td>Distribution</td>
</tr>
<tr>
<td class="label">PLCB1a</td>
<td>Neurons, widespread</td>
</tr>
<tr>
<td class="label">PLCB1b</td>
<td>Testis, some brain regions</td>
</tr>
<tr>
<td class="label">Receptor Family</td>
<td>Examples</td>
</tr>
<tr>
<td class="label">Muscarinic ACh</td>
<td>M1, M3, M5</td>
</tr>
<tr>
<td class="label">Metabotropic glutamate</td>
<td>mGluR1, mGluR5</td>
</tr>
<tr>
<td class="label">Serotonin</td>
<td>5-HT2A, 5-HT2C</td>
</tr>
<tr>
<td class="label">Alpha-adrenergic</td>
<td>alpha1A, alpha1B</td>
</tr>
<tr>
<td class="label">Dopamine</td>
<td>D1-like (indirect)</td>
</tr>
<tr>
<td class="label">Agent</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">U73122</td>
<td>PLC inhibitor</td>
</tr>
<tr>
<td class="label">U73343</td>
<td>Inactive analog control</td>
</tr>
<tr>
<td class="label">Mecamylamine</td>
<td>Nicotinic antagonist (affects PLC)</td>
</tr>
<tr>
<td class="label">Lithium</td>
<td>Indirect PLC modulation</td>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>Expression</td>
</tr>
<tr>
<td class="label">Pyramidal neurons</td>
<td>High</td>
</tr>
<tr>
<td class="label">Interneurons</td>
<td>High</td>
</tr>
<tr>
<td class="label">Purkinje cells</td>
<td>Very high</td>
</tr>
<tr>
<td class="label">Astrocytes</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

PLCB1 (Phospholipase C Beta 1) encodes phospholipase C beta 1, a critical enzyme in the phosphoinositide signaling pathway. PLCB1 hydrolyzes phosphatidylinositol 4,5-bisphosphate (PIP2) to generate two important second messengers: inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). These molecules regulate calcium release from intracellular stores and activate protein kinase C (PKC), respectively, making PLCB1 essential for numerous neuronal functions including synaptic plasticity, learning, memory, and neuronal development["@yang2020"].

Protein Structure and Function

Isoforms

PLCB1 has two main splice isoforms:

Domain Architecture

PLCβ1 contains several distinct domains:

PH domain (Pleckstrin Homology): Located at the N-terminus, binds PIP2 at the membrane

EF-hand domain: Calcium-binding regulatory region

X domain: Part of the catalytic core

Y domain: Catalytic core (with X domain)

C2 domain: Calcium-dependent membrane association

C-terminal regulatory domain: Contains the effector loop for Gq activation

Catalytic Mechanism

PLCβ1 hydrolyzes PIP2 through a two-step process:

Membrane recruitment: PH domain binds PIP2 at the plasma membrane

Catalysis: X and Y domains hydrolyze PIP2 to IP3 + DAG

The enzyme is activated by Gq-coupled receptors and can also be activated by Gβγ subunits[@riekenberg2009].

Normal Physiological Functions

Synaptic Plasticity

PLCβ1 is crucial for both long-term potentiation (LTP) and long-term depression (LTD):

LTP:

Gq-coupled receptors (mGluR1, muscarinic ACh receptors) activate PLCB1
IP3-mediated Ca2+ release contributes to LTP induction
PKC activation is required for LTP maintenance

LTD:

mGluR1/5 activation triggers PLC signaling
Internal calcium release is essential for LTD
PKC contributes to AMPA receptor internalization[@kim2017]

Calcium Signaling

PLCβ1-generated IP3 binds IP3 receptors (IP3R) on the endoplasmic reticulum:

Triggers Ca2+ release from ER stores
Generates intracellular calcium oscillations
Regulates Ca2+-dependent gene transcription via CaMKIV

Receptor Signaling

PLCB1 is activated by numerous Gq-coupled receptors:

Dendritic Spine Morphology

PLC signaling regulates spine structure:

PLCB1 activity influences spine size and density
PKC activation affects actin cytoskeleton
Ca2+ release modulates spine remodeling

Role in Neurodegenerative Diseases

Alzheimer's Disease

PLCB1 dysfunction is implicated in AD pathogenesis[@jang2019]:

Mechanisms:

APP processing: Aβ affects PLC signaling pathways
Tau pathology: Hyperphosphorylated tau alters PLC localization
Synaptic failure: Reduced PLCB1 expression in AD brain
Calcium dysregulation: IP3-mediated Ca2+ signaling impaired

Evidence:

Postmortem AD brain shows reduced PLCB1 levels
Aβ oligomers inhibit PLCB1 activity
PLCB1 knockout mice show memory deficits
PLC activators show protective effects in models

Parkinson's Disease

PLC signaling is altered in PD[@ross2018]:

Dopamine receptor signaling:

D1 receptors can couple to Gq (through Gs/Gq switch)
D2 receptors can signal through Gβγ to PLC
Alpha-synuclein aggregation affects PLC pathway

Neuroinflammation:

Microglial PLCB1 contributes to inflammatory responses
Cytokine signaling involves PLC pathways

Epilepsy

PLCB1 mutations are associated with epileptic encephalopathies[@yang2018]:

De novo missense mutations cause Ohtahara syndrome
Loss of PLCB1 function leads to neuronal hyperexcitability
Altered calcium homeostasis affects seizure thresholds

Intellectual Disability

PLCB1 variants contribute to neurodevelopmental disorders[@zhou2019]:

Missense mutations in patients with ID
Haploinsufficiency affects brain development
Often comorbid with epilepsy and autism

Clinical Significance

Ohtahara Syndrome (Early Infantile Epileptic Encephalopathy)

PLCB1 mutations cause severe early-onset epilepsy:

Onset in first months of life
Profound developmental impairment
Refractory seizures
Poor prognosis

Autism Spectrum Disorder

PLCB1 variants found in ASD patients
Synaptic PLC signaling affects social behavior
Often co-occurs with intellectual disability

Schizophrenia

Altered PLCB1 expression in postmortem brain
Dysregulated phosphoinositide signaling
May contribute to cognitive deficits

Therapeutic Targeting

Pharmacological Modulators

Drug Development

PLCβ1-selective activators: Cognitive enhancement
PLCβ1 inhibitors: Anticonvulsant potential
mGluR5 modulators: Indirect PLC activation
IP3 receptor modulators: Downstream targeting[@smith2020]

Expression Pattern

Brain Regions

PLCB1 is highly expressed in:

Cerebral cortex (layers II-VI)
Hippocampus (CA1-CA3, dentate gyrus)
Cerebellum (Purkinje cells)
Basal ganglia
[Thalamus](/brain-regions/thalamus)

Cell Type Specificity

Animal Models

Knockout Mice

Plcb1-/-: Viable but with severe phenotypes
Impaired spatial learning: Morris water maze deficits
Reduced LTP: Hippocampal slice recordings
Seizure susceptibility: Lower threshold

Conditional Knockouts

Neuron-specific: Finer phenotypic analysis
Brain region-specific: Cortical vs hippocampal
Developmental: Timing-specific deletion

Transgenic Models

Human variants: Express patient mutations
Overexpression: Gain-of-function studies

Signaling Pathways

Gq-PLC Pathway

Receptor activation → Gq protein → PLCB1 activation → PIP2 hydrolysis
↓
IP3 + DAG
↓ ↓
Ca2+ release PKC activation
↓ ↓
Gene transcription Synaptic plasticity

Cross-talk with Other Pathways

cAMP/PKA: PLCB1 can modulate adenylate cyclase
MAPK/ERK: PKC activates downstream kinases
PI3K/Akt: IP3-mediated Ca2+ affects Akt signaling

Gene Variation

Pathogenic Variants

Missense mutations: Predominantly in catalytic domains
Nonsense mutations: Haploinsufficiency
Splice variants: Altered isoform expression

Polymorphisms

Common variants in non-coding regions
Some associated with psychiatric disease
Population-specific allele frequencies

Research Methods

Biochemistry

PIP2 hydrolysis assays
IP3 measurement (mass assays)
DAG quantification

Electrophysiology

Whole-cell patch-clamp
Calcium imaging (fluorescence)
LTP/LTD induction protocols

Molecular Biology

siRNA/shRNA knockdown
CRISPR-Cas9 editing
Co-immunoprecipitation

References

[Yang et al., PLC-beta signaling in neuronal function (2020)](https://pubmed.ncbi.nlm.nih.gov/31621042/)

[Riekenberg et al., PLC-beta isoforms (2009)](https://pubmed.ncbi.nlm.nih.gov/19007879/)

[Hossain et al., PLCbeta4 in neural development (2008)](https://pubmed.ncbi.nlm.nih.gov/18666273/)

[De et al., PLCB1 and neuropsychiatric disorders (2021)](https://pubmed.ncbi.nlm.nih.gov/33452374/)

[Kim et al., PLC in synaptic plasticity (2017)](https://pubmed.ncbi.nlm.nih.gov/28342921/)

[Fukami et al., PLCbeta and disease (2010)](https://pubmed.ncbi.nlm.nih.gov/20185032/)

[Jang et al., PLC signaling in AD (2019)](https://pubmed.ncbi.nlm.nih.gov/31329583/)

[Yang et al., PLCB1 variants in epilepsy (2018)](https://pubmed.ncbi.nlm.nih.gov/29574835/)

[Choi et al., PLC in dopamine signaling (2020)](https://pubmed.ncbi.nlm.nih.gov/33106596/)

[Martin et al., PLC and synaptic scaling (2015)](https://pubmed.ncbi.nlm.nih.gov/25653556/)

[Thompson et al., PLC in learning and memory (2017)](https://pubmed.ncbi.nlm.nih.gov/28356525/)

[Wilson et al., PLC in neurite outgrowth (2016)](https://pubmed.ncbi.nlm.nih.gov/27012482/)

[Ross et al., PLC in PD (2018)](https://pubmed.ncbi.nlm.nih.gov/29859619/)

[Zhou et al., PLCB1 and ID (2019)](https://pubmed.ncbi.nlm.nih.gov/30668599/)

[Anderson et al., PLC in cortical development (2020)](https://pubmed.ncbi.nlm.nih.gov/32291056/)

[Caille et al., PLC in astrocytes (2019)](https://pubmed.ncbi.nlm.nih.gov/31176018/)

[Liu et al., PLC and LTD (2021)](https://pubmed.ncbi.nlm.nih.gov/33891673/)

[Smith et al., Targeting PLC in brain disorders (2020)](https://pubmed.ncbi.nlm.nih.gov/32690573/)

[Hernandez et al., PLC in cerebellum (2018)](https://pubmed.ncbi.nlm.nih.gov/29497942/)

[Park et al., PLC and AMPA trafficking (2019)](https://pubmed.ncbi.nlm.nih.gov/31126995/)

Last updated: 2026-03-25

Pathway Diagram

The following diagram shows the key molecular relationships involving PLCB1 Gene discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

PLCB1

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-plcb1
kg_node_id	PLCB1
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-0ec6f3099d31
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-plcb1'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

35%

Debates

0

Incoming

7

Outgoing

17

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

PLCB1 Gene

PLCB1 Gene

Overview

PLCB1 Gene

Overview

Protein Structure and Function

Isoforms

Domain Architecture

Catalytic Mechanism

Normal Physiological Functions

Synaptic Plasticity

Calcium Signaling

Receptor Signaling

Dendritic Spine Morphology

Role in Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease

Epilepsy

Intellectual Disability

Clinical Significance

Ohtahara Syndrome (Early Infantile Epileptic Encephalopathy)

Autism Spectrum Disorder

Schizophrenia

Therapeutic Targeting

Pharmacological Modulators

Drug Development

Expression Pattern

Brain Regions

Cell Type Specificity

Animal Models

Knockout Mice

Conditional Knockouts

Transgenic Models

Signaling Pathways

Gq-PLC Pathway

Cross-talk with Other Pathways

Gene Variation

Pathogenic Variants

Polymorphisms

Research Methods

Biochemistry

Electrophysiology

Molecular Biology

See Also

References

Pathway Diagram

💬 Discussion